513 related articles for article (PubMed ID: 33397266)
1. Nicotinamide as a Foundation for Treating Neurodegenerative Disease and Metabolic Disorders.
Maiese K
Curr Neurovasc Res; 2021; 18(1):134-149. PubMed ID: 33397266
[TBL] [Abstract][Full Text] [Related]
2. Nicotinamide: Oversight of Metabolic Dysfunction Through SIRT1, mTOR, and Clock Genes.
Maiese K
Curr Neurovasc Res; 2020; 17(5):765-783. PubMed ID: 33183203
[TBL] [Abstract][Full Text] [Related]
3. The impact of aging and oxidative stress in metabolic and nervous system disorders: programmed cell death and molecular signal transduction crosstalk.
Maiese K
Front Immunol; 2023; 14():1273570. PubMed ID: 38022638
[TBL] [Abstract][Full Text] [Related]
4. Novel Treatment Strategies for the Nervous System: Circadian Clock Genes, Non-coding RNAs, and Forkhead Transcription Factors.
Maiese K
Curr Neurovasc Res; 2018; 15(1):81-91. PubMed ID: 29557749
[TBL] [Abstract][Full Text] [Related]
5. Novel nervous and multi-system regenerative therapeutic strategies for diabetes mellitus with mTOR.
Maiese K
Neural Regen Res; 2016 Mar; 11(3):372-85. PubMed ID: 27127460
[TBL] [Abstract][Full Text] [Related]
6. Moving to the Rhythm with Clock (Circadian) Genes, Autophagy, mTOR, and SIRT1 in Degenerative Disease and Cancer.
Maiese K
Curr Neurovasc Res; 2017; 14(3):299-304. PubMed ID: 28721811
[TBL] [Abstract][Full Text] [Related]
7. Warming Up to New Possibilities with the Capsaicin Receptor TRPV1: mTOR, AMPK, and Erythropoietin.
Maiese K
Curr Neurovasc Res; 2017; 14(2):184-189. PubMed ID: 28294062
[TBL] [Abstract][Full Text] [Related]
8. Forkhead Transcription Factors: Formulating a FOXO Target for Cognitive Loss.
Maiese K
Curr Neurovasc Res; 2017; 14(4):415-420. PubMed ID: 29149835
[TBL] [Abstract][Full Text] [Related]
9. The mechanistic target of rapamycin (mTOR) and the silent mating-type information regulation 2 homolog 1 (SIRT1): oversight for neurodegenerative disorders.
Maiese K
Biochem Soc Trans; 2018 Apr; 46(2):351-360. PubMed ID: 29523769
[TBL] [Abstract][Full Text] [Related]
10. Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders.
Maiese K
Br J Clin Pharmacol; 2016 Nov; 82(5):1245-1266. PubMed ID: 26469771
[TBL] [Abstract][Full Text] [Related]
11. Cognitive Impairment and Dementia: Gaining Insight through Circadian Clock Gene Pathways.
Maiese K
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356626
[TBL] [Abstract][Full Text] [Related]
12. New Insights for nicotinamide: Metabolic disease, autophagy, and mTOR.
Maiese K
Front Biosci (Landmark Ed); 2020 Jun; 25(11):1925-1973. PubMed ID: 32472766
[TBL] [Abstract][Full Text] [Related]
13. Cellular Metabolism: A Fundamental Component of Degeneration in the Nervous System.
Biomolecules; ; . PubMed ID: 37238686
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
